In addition, removing HSPG with an enzyme or using heparin (competitive binding S protein) can prevent SARS-CoV-2 from binding to HSPG on the cell surface, hinder the adsorption of virus to host cells, and thus inhibit viral infection. This evidence concerns the gene PROS1 and viral infectious disease.